The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Brepocitinib 45 mg once-daily achieved statistically significant benefit compared to placebo on the primary and all key secondary endpoints for each of CLARITY-1 and CLARITY-2, the two identical Phase ...
Carey said the take-home message is “if you have a patient who’s had MS and optic neuritis, and they call your office saying, ...
A study of 30.7 million US children revealed that pediatric uveitis incidence rose from 22 to 33 per 100,000 between 2016 and 2025.
Timothy Janetos, MD, outlined can’t-miss uveitis diagnoses, warning signs, and why every new patient needs dilation. The course is designed for comprehensive and pediatric ophthalmologists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results